Page last updated: 2024-08-24

cholesteryl succinate and Disease Models, Animal

cholesteryl succinate has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
He, H; Jia, J; Li, Z; Liu, J; Wang, J; Zhang, W	1
Adami, R; Bell, S; Brown, T; Charmley, P; Chen, F; Chen, Y; Fam, R; Farber, K; Fosnaugh, K; Harvie, P; Houston, ME; Johns, R; Kwang, E; Liu, Y; Maciagiewicz, I; Matsui, Y; McCutcheon, M; Polisky, B; Seth, S; Severson, G; So, A; Takagi, A; Templin, MV; Vaish, N; Zhu, T	1

Other Studies

2 other study(ies) available for cholesteryl succinate and Disease Models, Animal

Article	Year
Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins. Drug delivery, 2013, Volume: 20, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Biomimetic Materials; Breast Neoplasms; Cholesterol Esters; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Female; Humans; Lipoproteins, HDL; Male; MCF-7 Cells; Mice; Mice, Inbred ICR; Paclitaxel; Particle Size; Phosphatidylcholine-Sterol O-Acyltransferase; Tissue Distribution	2013
RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer. Molecular therapy : the journal of the American Society of Gene Therapy, 2011, Volume: 19, Issue:5 Topics: Administration, Intravesical; Animals; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cholesterol; Cholesterol Esters; Disease Models, Animal; Female; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Liposomes; Mice; Mice, Nude; Phosphatidylethanolamines; Polo-Like Kinase 1; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Repressor Proteins; RNA Interference; RNA, Messenger; RNA, Small Interfering; Survivin; Urinary Bladder Neoplasms	2011

Article

Year

Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.

Drug delivery, 2013, Volume: 20, Issue:8

Topics: Animals; Antineoplastic Agents, Phytogenic; Biomimetic Materials; Breast Neoplasms; Cholesterol Esters; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Female; Humans; Lipoproteins, HDL; Male; MCF-7 Cells; Mice; Mice, Inbred ICR; Paclitaxel; Particle Size; Phosphatidylcholine-Sterol O-Acyltransferase; Tissue Distribution

2013

RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer.

Molecular therapy : the journal of the American Society of Gene Therapy, 2011, Volume: 19, Issue:5

Topics: Administration, Intravesical; Animals; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Cholesterol; Cholesterol Esters; Disease Models, Animal; Female; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Liposomes; Mice; Mice, Nude; Phosphatidylethanolamines; Polo-Like Kinase 1; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Repressor Proteins; RNA Interference; RNA, Messenger; RNA, Small Interfering; Survivin; Urinary Bladder Neoplasms

2011